Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. (Reannouncement with new availability information)
Purified fetal bovine serum acetylcholinesterase (FBS AChE) and horse serum butyrylcholinesterase (BChE) were successfully used as single pretreatment drugs for the prevention of pinacolyl methylphosphonofluoridate (soman) toxicity in nonhuman primates. Eight rhesus monkeys, trained to perform Primate Equilibrium Platform (PEP) tasks, were pretreated with FBS AChE or BChE and challenged with a cumulative level of five median lethal doses (LD 50) of soman. All ChE-pretreated monkeys survived the soman challenge and showed no symptoms of soman toxicity. A quantitative linear relation was observed between the soman dose and the neutralization of blood ChE. None of the four AChE-pretreated animals showed PEP task decrements, even though administration of soman irreversibly inhibited nearly all of the exogenously administered AChE. In two of four BChE pretreated animals, a small transient PEP performance decrement occurred when the cumulative soman dose exceeded 4 LD 50. Performance decrements observed under BCh E protection mete modest by the usual standards of organophosphorus compound toxicity. No residual or delayed performance decrements or other untoward effects were observed during 6 weeks of postexposure testing with either ChE.... Cholinesterases, Pretreatment, Soman, AChE, BChE, Toxicity.
- Research Organization:
- Walter Reed Army Inst. of Research, Washington, DC (United States). Div. of Biochemistry
- OSTI ID:
- 189795
- Report Number(s):
- AD-A-259568/4/XAB; TRN: 60360285
- Resource Relation:
- Other Information: PBD: 1992
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cholinesterases as scavengers for organophosphorus compounds: Protection of primate performance against soman toxicity. (Reannouncement with new availability information)
Protection of Rhesus monkeys against Soman and prevention of performance decrement by pretreatment with acetylcholinesterase. (Reannouncement with new availability information)